Gsk
GSK's India unit Q3 profit up 9% as input costs slump, op revenue fell 1.7%
GlaxoSmithKline Pharmaceuticals Ltd, the Indian unit of UK's GSK plc, reported a 9.5% rise in profit, in line with analysts' estimates, as a sharp drop in input costs more than offset revenue decline
 "GSK's India unit Q3 profit up 9% as input costs slump, op revenue fell 1.7%")
GlaxoSmithKline Pharma Q2 net up 3% to Rs 193 cr, revenue down to Rs 906 cr
GlaxoSmithKline Pharmaceuticals on Friday said its net profit increased 3 per cent to Rs 193 crore in the second quarter ended September. The drug maker had reported a net profit from continuing operations at Rs 187 crore in the July-September period of the previous fiscal. However, revenue from operations declined to Rs 906 crore in the second quarter of the current fiscal compared to Rs 916 crore in the year-ago period, GlaxoSmithKline Pharmaceuticals said in a regulatory filing. "GSK India has delivered another quarter of strong performance in general medicines and specialty business, gaining market share. We hope to build on this momentum in the coming quarters and continue to focus on our key brands to drive sustainable profitable growth," GlaxoSmithKline Pharmaceuticals Managing Director Sridhar Venkatesh said. Vaccines business was impacted due to low vaccination rates as the overall market for the self-pay segment in which the company operates continues to decline, he ...
 "GlaxoSmithKline Pharma Q2 net up 3% to Rs 193 cr, revenue down to Rs 906 cr")
Burberry's Julie Brown is GSK's first ever female CFO, says report
Brown, also 60, will join GSK in April and take up the job in May. She has extensive experience in the health and pharmaceutical industry.
 "Burberry's Julie Brown is GSK's first ever female CFO, says report")
Sanofi, GSK and Haleon lead $40-billion rout on heartburn drug
Sanofi fell 13% on Thursday, taking its 2-day decline to 20%; GSK slid 6.9%
 "Sanofi, GSK and Haleon lead $40-billion rout on heartburn drug")
Sanofi, GSK say Covid booster shot works better against Omicron variant
The companies point to the risk of new variants and waning immunity that could lead to an increase in demand for additional booster shots in some populations.
 "Sanofi, GSK say Covid booster shot works better against Omicron variant")
US pulls GSK's Covid drug as omicron sibling dominates cases
GlaxoSmithKline's IV drug for Covid-19 should no longer be used because it is likely ineffective against the omicron subvariant that now accounts for most US cases, federal health regulators said
Sanofi, GSK to seek regulatory approval for Covid vaccine candidate
Sanofi-GSK's shot relies on a conventional protein-based approach, compared with the newer mRNA technology used in established Covid-19 vaccines from Pfizer-BioNTech and Moderna
 "Sanofi, GSK to seek regulatory approval for Covid vaccine candidate")
CCPA passes order for discontinuation of Sensodyne ads in India
Consumer protection regulator CCPA has passed an order against GlaxoSmithKline Consumer Healthcare Ltd directing it to discontinue advertisements of Sensodyne products in India for flouting norms.
 "CCPA passes order for discontinuation of Sensodyne ads in India")
Unilever to sell slow-growth brands as it weighs higher bid for GSK unit
The Dove soap owner said Monday it will announce a revamp of its structure later this month
 "Unilever to sell slow-growth brands as it weighs higher bid for GSK unit")
Unilever eyes GSK's consumer goods arm in possible $68-bn deal
Unilever confirms interest in GSK assets, says GSK consumer business would be 'strong strategic fit'; UK's Sunday Times says 50 billion-pound bid rejected in late 2021
 "Unilever eyes GSK's consumer goods arm in possible $68-bn deal")
How the world's first malaria vaccine will protect against the parasite
This vaccine has been in development for 30 long years
 "How the world's first malaria vaccine will protect against the parasite")
GSK, CureVac's next-gen Covid vaccine shows promise in monkey trial
The encouraging news on its "second-generation" vaccine gave CureVac's German-listed shares an 8% lift, as the stock gradually recovers from a slump in June
Sanofi-GSK Covid-19 vaccine gets nod to start phase-3 trials in India
India part of 35,000 volunteer global efficacy trial
 "Sanofi-GSK Covid-19 vaccine gets nod to start phase-3 trials in India")
GSK's drugs arm to get $11 billion windfall from consumer spin-off
Investors have been waiting for details of the separation
Activist investor Elliott takes multibillion pound stake in GSK: Report
Shares in GSK erased losses and traded more than 7% higher
 "Activist investor Elliott takes multibillion pound stake in GSK: Report")
GSK fires former US govt vaccine head Slaoui over harassment allegation
GlaxoSmithKline has dismissed Moncef Slaoui as chairman of a company controlled by the British drugmaker after an internal investigation found he had sexually harassed an employee several years ago
 "GSK fires former US govt vaccine head Slaoui over harassment allegation")
GSK fires former US govt vaccine head Slaoui over harassment allegation
Former U.S. President Donald Trump appointed Slaoui to lead his administration's effort to produce and distribute COVID-19 vaccines last year
 "GSK fires former US govt vaccine head Slaoui over harassment allegation")
GSK, CureVac to develop Covid-19 vaccines aimed at new variants
Drugmaker GlaxoSmithKline said Wednesday it will work with a German biopharmaceutical company to develop new vaccines targeting emerging variants of COVID-19
British firm GSK to move malaria vaccine production to Bharat Biotech
The agreement includes transfer of manufacturing of the protein part of the malaria vaccine
GSK transfers malaria vaccine production to India's Bharat Biotech
The agreement includes transfer of manufacturing of the protein part of the vaccine
